Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
EBV-specific anti-PD1 TCR-T cells / TCRCure
NCT04509726: EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal Carcinoma	Suspended	1/2	20	RoW	EBV-specific TCR-T cell with cytokine auto-secreting element	Xinqiao Hospital of Chongqing, TCRCure Biopharma Ltd.	Nasopharyngeal Carcinoma	12/24	12/24
NCT04139057: EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC	Suspended	1/2	18	RoW	EBV-specific TCR-T cell with anti-PD1 auto-secreted element	Xinqiao Hospital of Chongqing, TCRCure Biopharma Ltd.	Head and Neck Squamous Cell Carcinoma	12/24	12/24